These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31710842)

  • 1. ECG AI-Guided Screening for Low Ejection Fraction (EAGLE): Rationale and design of a pragmatic cluster randomized trial.
    Yao X; McCoy RG; Friedman PA; Shah ND; Barry BA; Behnken EM; Inselman JW; Attia ZI; Noseworthy PA
    Am Heart J; 2020 Jan; 219():31-36. PubMed ID: 31710842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial.
    Yao X; Rushlow DR; Inselman JW; McCoy RG; Thacher TD; Behnken EM; Bernard ME; Rosas SL; Akfaly A; Misra A; Molling PE; Krien JS; Foss RM; Barry BA; Siontis KC; Kapa S; Pellikka PA; Lopez-Jimenez F; Attia ZI; Shah ND; Friedman PA; Noseworthy PA
    Nat Med; 2021 May; 27(5):815-819. PubMed ID: 33958795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study.
    Bachtiger P; Petri CF; Scott FE; Ri Park S; Kelshiker MA; Sahemey HK; Dumea B; Alquero R; Padam PS; Hatrick IR; Ali A; Ribeiro M; Cheung WS; Bual N; Rana B; Shun-Shin M; Kramer DB; Fragoyannis A; Keene D; Plymen CM; Peters NS
    Lancet Digit Health; 2022 Feb; 4(2):e117-e125. PubMed ID: 34998740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care.
    Rushlow DR; Croghan IT; Inselman JW; Thacher TD; Friedman PA; Yao X; Pellikka PA; Lopez-Jimenez F; Bernard ME; Barry BA; Attia IZ; Misra A; Foss RM; Molling PE; Rosas SL; Noseworthy PA
    Mayo Clin Proc; 2022 Nov; 97(11):2076-2085. PubMed ID: 36333015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope
    Attia ZI; Dugan J; Rideout A; Maidens JN; Venkatraman S; Guo L; Noseworthy PA; Pellikka PA; Pham SL; Kapa S; Friedman PA; Lopez-Jimenez F
    Eur Heart J Digit Health; 2022 Sep; 3(3):373-379. PubMed ID: 36712160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial design data for electrocardiogram artificial intelligence-guided screening for low ejection fraction (EAGLE).
    Yao X; McCoy RG; Friedman PA; Shah ND; Barry BA; Behnken EM; Inselman JW; Attia ZI; Noseworthy PA
    Data Brief; 2020 Feb; 28():104894. PubMed ID: 31867424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction.
    Attia ZI; Kapa S; Yao X; Lopez-Jimenez F; Mohan TL; Pellikka PA; Carter RE; Shah ND; Friedman PA; Noseworthy PA
    J Cardiovasc Electrophysiol; 2019 May; 30(5):668-674. PubMed ID: 30821035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence Algorithm for Screening Heart Failure with Reduced Ejection Fraction Using Electrocardiography.
    Cho J; Lee B; Kwon JM; Lee Y; Park H; Oh BH; Jeon KH; Park J; Kim KH
    ASAIO J; 2021 Mar; 67(3):314-321. PubMed ID: 33627606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence ECG to Detect Left Ventricular Dysfunction in COVID-19: A Case Series.
    Attia ZI; Kapa S; Noseworthy PA; Lopez-Jimenez F; Friedman PA
    Mayo Clin Proc; 2020 Nov; 95(11):2464-2466. PubMed ID: 33153634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Effectiveness of an Electrocardiographic Deep Learning Algorithm to Detect Asymptomatic Left Ventricular Dysfunction.
    Tseng AS; Thao V; Borah BJ; Attia IZ; Medina Inojosa J; Kapa S; Carter RE; Friedman PA; Lopez-Jimenez F; Yao X; Noseworthy PA
    Mayo Clin Proc; 2021 Jul; 96(7):1835-1844. PubMed ID: 34116837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design.
    Adedinsewo DA; Morales-Lara AC; Dugan J; Garzon-Siatoya WT; Yao X; Johnson PW; Douglass EJ; Attia ZI; Phillips SD; Yamani MH; Tobah YB; Rose CH; Sharpe EE; Lopez-Jimenez F; Friedman PA; Noseworthy PA; Carter RE
    Am Heart J; 2023 Jul; 261():64-74. PubMed ID: 36966922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial.
    Ashburner JM; Atlas SJ; McManus DD; Chang Y; Trisini Lipsanopoulos AT; Borowsky LH; Guan W; He W; Ellinor PT; Singer DE; Lubitz SA
    Am Heart J; 2019 Sep; 215():147-156. PubMed ID: 31326680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial.
    Noseworthy PA; Attia ZI; Behnken EM; Giblon RE; Bews KA; Liu S; Gosse TA; Linn ZD; Deng Y; Yin J; Gersh BJ; Graff-Radford J; Rabinstein AA; Siontis KC; Friedman PA; Yao X
    Lancet; 2022 Oct; 400(10359):1206-1212. PubMed ID: 36179758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence-Augmented Electrocardiogram Detection of Left Ventricular Systolic Dysfunction in the General Population.
    Kashou AH; Medina-Inojosa JR; Noseworthy PA; Rodeheffer RJ; Lopez-Jimenez F; Attia IZ; Kapa S; Scott CG; Lee AT; Friedman PA; McKie PM
    Mayo Clin Proc; 2021 Oct; 96(10):2576-2586. PubMed ID: 34120755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular systolic dysfunction identification using artificial intelligence-augmented electrocardiogram in cardiac intensive care unit patients.
    Jentzer JC; Kashou AH; Attia ZI; Lopez-Jimenez F; Kapa S; Friedman PA; Noseworthy PA
    Int J Cardiol; 2021 Mar; 326():114-123. PubMed ID: 33152415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality risk stratification using artificial intelligence-augmented electrocardiogram in cardiac intensive care unit patients.
    Jentzer JC; Kashou AH; Lopez-Jimenez F; Attia ZI; Kapa S; Friedman PA; Noseworthy PA
    Eur Heart J Acute Cardiovasc Care; 2021 Jun; 10(5):532-541. PubMed ID: 33620440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence for detecting mitral regurgitation using electrocardiography.
    Kwon JM; Kim KH; Akkus Z; Jeon KH; Park J; Oh BH
    J Electrocardiol; 2020; 59():151-157. PubMed ID: 32146201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review.
    Jones OT; Calanzani N; Saji S; Duffy SW; Emery J; Hamilton W; Singh H; de Wit NJ; Walter FM
    J Med Internet Res; 2021 Mar; 23(3):e23483. PubMed ID: 33656443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Artificial intelligence-based ECG analysis: current status and future perspectives-Part 2 : Recent studies and future].
    Haverkamp W; Strodthoff N; Israel C
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):305-311. PubMed ID: 35552487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.